179 related articles for article (PubMed ID: 30360598)
1. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
3. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
5. Increased plasmatic soluble HLA-G levels in endometrial cancer.
Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
[TBL] [Abstract][Full Text] [Related]
6. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
7. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.
Li JB; Ruan YY; Hu B; Dong SS; Bi TN; Lin A; Yan WH
Oncotarget; 2017 Jul; 8(30):48854-48862. PubMed ID: 28415627
[TBL] [Abstract][Full Text] [Related]
8. HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer.
Lázaro-Sánchez AD; Salces-Ortiz P; Velásquez LI; Orozco-Beltrán D; Díaz-Fernández N; Juárez-Marroquí A
Clin Transl Oncol; 2020 Jul; 22(7):1166-1171. PubMed ID: 31748960
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer.
Mejía-Guarnizo LV; Monroy-Camacho PS; Rincón-Rodríguez DE; Rincón-Riveros A; Martinez-Vargas DA; Huertas-Caro CA; Oliveros-Wilches R; Sanchez-Pedraza R; Nuñez-Lemus M; Cristancho-Lievano CF; Castellanos-Moreno AM; Martinez-Correa LM; Rodríguez-García JA
Sci Rep; 2023 Aug; 13(1):13119. PubMed ID: 37573450
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
12. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
13. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
[TBL] [Abstract][Full Text] [Related]
14. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
Shi WW; Lin A; Xu DP; Bao WG; Zhang JG; Chen SY; Li J; Yan WH
Hum Immunol; 2011 Nov; 72(11):1068-73. PubMed ID: 21762747
[TBL] [Abstract][Full Text] [Related]
15. Elevation of HLA-G-expressing DC-10 cells in patients with gastric cancer.
Xu DP; Shi WW; Zhang TT; Lv HY; Li JB; Lin A; Yan WH
Hum Immunol; 2016 Sep; 77(9):800-4. PubMed ID: 26773190
[TBL] [Abstract][Full Text] [Related]
16. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
17. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.
Klitkou L; Dahl M; Hviid TV; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Christiansen OB
Hum Immunol; 2015 Apr; 76(4):254-9. PubMed ID: 25636573
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection.
Laaribi AB; Bortolotti D; Hannachi N; Mehri A; Hazgui O; Ben Yahia H; Babay W; Belhadj M; Chaouech H; Yacoub S; Letaief A; Ouzari HI; Boudabous A; Di Luca D; Boukadida J; Rizzo R; Zidi I
J Viral Hepat; 2017 Nov; 24(11):1016-1022. PubMed ID: 28429836
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-G*01:01:02:01/G*01:04:01 polymorphism with gastric adenocarcinoma.
Khorrami S; Rahimi R; Mohammadpour H; Bahrami S; Yari F; Poustchi H; Malekzadeh R
Hum Immunol; 2016 Feb; 77(2):153-7. PubMed ID: 26585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
